Tech Company Financing Transactions
Juvenescence Funding Round
Juvenescence, operating out of Tortola, raised $76 million from M42 Health and private investors.
Transaction Overview
Company Name
Announced On
5/21/2025
Transaction Type
Venture Equity
Amount
$76,000,000
Round
Series B
Investors
M42 Health (Lead Investor) (Fahed Al Marzooqi)
Proceeds Purpose
The fresh capital will propel Juvenescence's pipeline of age-related disease therapies into later-stage clinical trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Craigmuir Chambers PO Box 71 Rd. Town
Tortola, VG1110
British Virgin Islands
Tortola, VG1110
British Virgin Islands
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Juvenescence Limited is a British Virgin Islands-based holding company that invests in human ageing and longevity. Juvenescence believes that recent scientific and medical advances will enable the development of therapeutics that meaningful extend human healthspan and eventually lifespan.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
James Mellon
Chief Executive Officer
Gregory Bailey
Chief Financial Officer
David Ellam
Chief Medical Officer
Declan Doogan
VP - R & D
Margaret Jackson
Browse more venture capital transactions:
Prev: 5/21/2025: Alt Carbon venture capital transaction
Next: 5/21/2025: Sublime Systems venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC transactions on this site are derived from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs